1. Home
  2. MOGU vs ASBP Comparison

MOGU vs ASBP Comparison

Compare MOGU & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MOGU Inc.

MOGU

MOGU Inc.

HOLD

Current Price

$2.48

Market Cap

21.8M

ML Signal

HOLD

Logo Aspire Biopharma Holdings Inc.

ASBP

Aspire Biopharma Holdings Inc.

HOLD

Current Price

$0.11

Market Cap

18.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGU
ASBP
Founded
2011
2021
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.8M
18.9M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
MOGU
ASBP
Price
$2.48
$0.11
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
6.9K
17.4M
Earning Date
11-21-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,462,964.00
$1,941.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.83
$0.07
52 Week High
$8.10
$15.80

Technical Indicators

Market Signals
Indicator
MOGU
ASBP
Relative Strength Index (RSI) 41.90 43.78
Support Level $2.39 $0.09
Resistance Level $2.71 $0.10
Average True Range (ATR) 0.13 0.01
MACD -0.01 0.01
Stochastic Oscillator 19.57 76.36

Price Performance

Historical Comparison
MOGU
ASBP

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

About ASBP Aspire Biopharma Holdings Inc.

Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.

Share on Social Networks: